Barinthus Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $14,969 | $0 | $0 | $5,369 |
Gross Profit | 14,969 | -1,468 | -1,429 | 3,921 |
EBITDA | -6,640 | -16,182 | -14,700 | -17,357 |
EBIT | -8,115 | -17,650 | -16,129 | -18,805 |
Net Income | -8,114 | -16,949 | -15,480 | -17,443 |
Net Change In Cash | 14,969 | 0 | 0 | 5,369 |
Free Cash Flow | -11,433 | -12,212 | -12,123 | -19,450 |
Cash | 106,102 | 117,774 | 129,971 | 142,090 |
Basic Shares | 39,419 | 39,041 | 38,773 | 38,602 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $802 | $44,703 | $268 | $4,821 |
Gross Profit | 802 | 44,703 | 268 | 4,821 |
EBITDA | -71,065 | 6,404 | -47,864 | -14,139 |
EBIT | -76,515 | 868 | -48,466 | -14,349 |
Net Income | -73,347 | 5,342 | -50,865 | -17,706 |
Net Change In Cash | 802 | 44,703 | 268 | 4,821 |
Cost of Revenue | 177,247 | |||
Free Cash Flow | -56,338 | -20,569 | -33,729 | -11,321 |
Cash | 142,090 | 194,385 | 214,054 | 43,266 |
Basic Shares | 38,386 | 38,169 | 37,188 | 47 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.21 |
2024-06-30 | -$0.43 |
2024-03-31 | -$0.40 |
2023-12-31 | -$0.45 |
